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Abstract
A key challenge in systems biology is the elucidation of the underlying prin-
ciples, or fundamental laws, which determine the cellular phenotype. Under-
standing how these fundamental principles are altered in diseases like cancer
is important for translating basic scientific knowledge into clinical advances.
While significant progress is being made, with the identification of novel drug
targets and treatments by means of systems biological methods, our funda-
mental systems level understanding of why certain treatments succeed and
others fail is still lacking. We here advocate a novel methodological frame-
work for systems analysis and interpretation of molecular omic data, which
is based on statistical mechanical principles. Specifically, we propose the
notion of cellular signalling entropy (or uncertainty), as a novel means of
analysing and interpreting omic data, and more fundamentally, as a means
of elucidating systems-level principles underlying basic biology and disease.
We describe the power of signalling entropy to discriminate cells according to
differentiation potential and cancer status. We further argue the case for an
empirical cellular entropy-robustness correlation theorem and demonstrate
its existence in cancer cell line drug sensitivity data. Specifically, we find
that high signalling entropy correlates with drug resistance and further de-
scribe how entropy could be used to identify the achilles heels of cancer cells.
In summary, signalling entropy is a deep and powerful concept, based on
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rigorous statistical mechanical principles, which, with improved data qual-
ity and coverage, will allow a much deeper understanding of the systems
biological principles underlying normal and disease physiology.
Keywords: entropy; network; signalling; genomics; drug resistance; cancer;
differentiation; stem cell
1. Introduction
Recent advances in biotechnology are allowing us to measure cellular
properties at an unprecedented level of detail [1]. For instance, it is now
possible to routinely measure various molecular entities (e.g. DNA methy-
lation, mRNA and protein expression, SNPs) genome-wide in hundreds if
not thousands of cellular specimens [2]. In addition, other molecular data
detailing interactions between proteins or between transcription factors and
regulatory DNA elements are growing at a rapid pace [1]. All these types of
data are now widely referred to collectively as “omic” data. The complexity
and high-dimensional nature of this omic data presents a daunting challenge
to those wishing to analyse and interpret the data [1]. The difficulty of
analysing omic data is further compounded by the inherent complexity of
cellular systems. Cells are prime examples of organized complex systems,
capable of highly stable and predictable behaviour, yet an understanding of
how this deterministic behaviour emerges from what is a highly complex and
probabilistic pattern of dynamic interactions between numerous intra and
extracellular components, still eludes us [1]. Thus, elucidating the systems-
biological laws or principles dictating cellular phenotypes is also key for an
improved analysis and interpretation of omic data. Furthermore, impor-
tant biological phenomena such as cellular differentiation are fundamentally
altered in diseases like cancer [3]. Hence, an attempt to understand how
cellular properties emerge at a systems level from the properties seen at the
individual gene level is not only a key endeavour for the systems biology com-
munity, but also for those wanting to translate basic insights into effective
medical advances [4, 5].
It is now well accepted that at a fundamental level most biological systems
are best modeled in terms of spatial interactions between specific entities
(e.g. neurons in the case of the brain), which may or may not be dynam-
ically changing in time [6, 7]. It therefore seems natural to also use the
mathematical and physical framework of networks to help us analyse and in-
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terpret omic data at a systems level [8, 9]. Indeed, the cellular phenotype is
determined to a large extent by the precise pattern of molecular interactions
taking place in the cell, i.e. a molecular interaction network [10]. Although
this network has spatial and dynamic dimensions which at present remain
largely unexplored due to technological or logistical limitations, there is al-
ready a growing number of examples where network-based analysis strategies
have been instrumental [11, 12, 13]. For instance, a deeper understanding
of why sustained treatment with EGFR inhibitors can lead to dramatic sen-
sitization of cancer cell lines to cytotoxic agents was possible thanks to a
systems approach [13]. Another study used reverse engineering network ap-
proaches to identify and validate drug targets in glioblastoma multiforme, to
be further tested in clinical trials [14]. What is key to appreciate here is that
these successes have been achieved in spite of noisy and incomplete data,
suggesting that there are simple yet deep systems biological principles un-
derlying cellular biology that we can already probe and exploit with current
technology and data. Thus, with future improvements in data quality and
coverage, network-based analysis frameworks will play an ever increasing and
important role in systems biology, specially at the level of systems analysis
and interpretation [4]. Therefore, it is also imperative to develop novel, more
powerful, network-theoretical methods for the systems analysis of omic data.
In adopting a network’s perspective for the analysis and interpretation of
omic data, there are in principle two different (but not mutually exclusive)
approaches one can take. One possibility is to infer (i.e. reverse engineer) the
networks from genome-wide data [15]. Most of these applications have done
this in the context of gene expression data, with the earliest approaches using
clustering or co-expression to postulate gene interdependencies [16]. Partial
correlations and Graphical Gaussian Models have proved useful as a means
of further refining correlation networks by allowing one to infer the more
likely direct interactions while simultaneously also filtering out those which
are more likely to be indirect [17]. These methods remain popular and con-
tinue to be studied and improved upon [18, 19]. Other methods have drawn
on advanced concepts from information theory, for instance ARACNe (“Al-
gorithm for the Reconstruction of Accurate Cellular Networks”) has been
shown to be successful in infering regulatory networks in B-cells [15].
In stark contrast to reverse engineering methods, another class of algorithms
have used structural biological networks from the outset, using these as scaf-
folds to integrate with omic data. Specifically, by using a structural network
one can sparsify the correlation networks inferred from reverse-engineering
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approaches, thus providing another means of filtering out correlations that
are more likely to be indirect [9]. Besides, integration with a structural net-
work automatically provides an improved framework for biological interpreta-
tion [10, 20, 21, 22]. The structural networks themselves are typically derived
from large databases, which detail literature curated experimentally veri-
fied interactions, including interactions derived from Yeast 2 Hybrid screens
(Y2H) [23]. The main example is that of protein protein interaction (PPI)
maps, which have been generated using a number of different complementary
experimental and in-silico approaches, and merging these maps from these
different sources together has been shown to be an effective approach in gen-
erating more comprehensive high-confidence interaction networks [24, 25].
PPI networks have been used mainly as a means of integrating and analysing
gene expression data (see e.g. [20, 26, 27]). More recently, this approach has
also been successfully applied in the DNA methylation context, for instance
it has been shown that epigenetic changes associated with age often target
specific gene modules and signalling pathways [28].
Another class of methods that have used structural networks, PPIs in par-
ticular, have integrated them with gene expression data to define an approx-
imation to the underlying signaling dynamics on the network, thus allowing
more in-depth exploration of the interplay between network topology and
gene expression. Typically, these studies have used the notion of random
walks on weighted graphs where the weights are constructed from differen-
tial expression statistics, and where the aim is to identify nodes (genes) in the
network which may be important in dictating the signaling flows within the
pathological state. For instance, among these random walk methods is Ne-
tRank, a modification of the Google PageRank algorithm, which was able to
identify novel, robust, network based biomarkers for survival time in various
cancers [29, 30]. Other random walk based approaches, aimed at identifying
causal drivers of specific phenotypes (e.g. expression or cancer), have mod-
eled signal transduction between genes in the causal and phenotypic layers
as flows in an electric circuit diagram, an elegant formulation capable of not
only identifying the likely causal genes but also of tracing the key pathways
of information flow or dysregulation [31, 32]. Random walk theory has also
been employed in the development of differential network methodologies. An
example is NetWalk [33], which is similar to NetRank but allows differential
signaling fluxes to be inferred. This approach was successful in identifying
and validating the glucose metabolic pathway as a key determinant of lapa-
tinib resistance in ERBB2 positive breast cancer patients [34].
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Another important concept to have emerged recently is that of network
rewiring [35, 36, 37]. This refers to the changes in interaction patterns that
accompany changes in the cellular phenotype. Network rewiring embodies
the concept that it is the changes in the interaction patterns, and not just
the changes in absolute gene expression or protein activity, that are the main
determinants of the cellular phenotype. That network rewiring may be key
to understanding cellular phenotypes was most convincingly demonstrated
in a differential epistasis mapping study conducted in yeast cells exposed to
a DNA damaging agent [35]. Specifically, what this study demonstrated is
that responses to perturbations or cellular stresses are best understood in
terms of the specific rewiring of protein complexes and functional modules.
Thus, this conceptual framework of network rewiring may apply equally well
to the genetic perturbations and cellular stresses underlying disease patholo-
gies like cancer.
In this article we advocate a network-theoretical framework based on statis-
tical mechanical principles and more specifically on the notion of signalling
entropy [8, 9]. This theoretical framework integrates gene expression (but
in principle also other functional data) with a PPI network, merging exist-
ing concepts such as signaling dynamics (i.e. random walks) and network
rewiring with that of signalling entropy. In previous work we have shown
how signalling entropy (i) provides a proxy to the elevation in Waddington’s
epigenetic landscape, correlating with a cell’s differentiation potential [38],
(ii) how it can be used to identify signaling pathways and nodes important
in differentiation and cancer [38, 8, 9], and (iii) how it predicts two cancer
system-omic hallmarks: (a) cancer is characterised by an increase in sig-
nalling entropy and (b) local signaling entropy changes anti-correlate with
differential gene expression [8, 9]. Here, we present and unify the different
signaling entropy measures used previously and further explore a novel ap-
plication of signalling entropy to understanding drug sensitivity profiles in
cancer cell lines. Specifically, we first use simulated data to justify the exis-
tence of an entropy-robustness theorem, and subsequently provide empirical
evidence for this theorem by demonstrating that increases in local signalling
entropy correlate with drug resistance (robustness). We further show the
importance of network topology in dictating the signalling entropy changes
underlying drug response. In addition, we provide R-functions implement-
ing the entropy rate calculation and ranking of genes according to differential
entropy, all freely available from sourceforge.net/projects/signalentropy/files/
.
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2. Materials and Methods
2.1. Basic rationale and motivation for Signalling Entropy: understanding
systems biology through uncertainty
Loosely defined, entropy of a system, refers to a measure of the disorder,
randomness or uncertainty of processes underlying the system’s state. In the
context of a single cell, signalling entropy will reflect the amount of overall
disorder, randomness or uncertainty in how information, i.e. signaling, is
passed on in the molecular interaction network. At a fundamental level, all
signaling in a cell is probabilistic, determined in part by the relative cellu-
lar concentrations of the interacting molecules. Hence, in discussing cellular
signalling entropy, it is useful to picture a molecular interaction network in
which edges represent possible interactions and with the edge weights reflect-
ing the relative probabilities of interaction (Fig.1A). Thus, an interaction
network in a high-entropy state is characterised by signaling interaction prob-
abilities that are all fairly similar in value, whereas a low-entropy state will
be characterised by specific signalling interactions possessing much higher
weights (Fig.1A).
Why would this type of signalling entropy, loosely defined as the amount
of uncertainty in the signaling interaction patterns, be useful to systems bi-
ology? One way to think of signalling entropy is as representing signaling
promiscuity, which has been proposed as a key systems feature underlying the
pluripotent or multipotent capacity of cells (Fig.1B) [39, 40, 41, 42]. Indeed,
it has been suggested that pluripotency is an intrinsic statistical mechanical
property, best defined at the cellular population level [40]. Specifically, it
has been demonstrated that pluripotent stem cells exhibit remarkable het-
erogeneity in gene expression levels, including well known stem cell markers
such as NANOG [40]. It is also well known that a large number of genes,
many encoding transcription factors, exhibit low-levels of expression in stem
cells, yet simultaneously are being kept in a poised chromatin state, allowing
immediate activation if this were required [43]. Thus, in a pluripotent stem
cell like state, signal transduction is in a highly egalitarian and, thus, promis-
cuous state, i.e. a state of high signalling entropy. Conversely, differentiation
leads, by necessity, to activation of specific transcription factors and path-
ways and thus to a lowering in the uncertainty of signaling patterns, and thus
to a lowering of entropy. We recently demonstrated, using gene expression
profiles of over 800 samples, comprising cells of all major stages of differen-
tiation, including human embryonic stem cells (hESCs), induced pluripotent
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stem cells (iPSCs), multipotent cell types (e.g. hematopoietic stem cells
(HSCs)), and terminally differentiated cells within these respective lineages,
that signalling entropy not only correlates with differentiation potential but
that it provides a highly quantitative measure of potency [38]. Indeed, we
showed that signalling entropy provides a reasonably good approximation to
the energy potential in Waddington’s epigenetic landscape [38].
Here we decided to explore the concept of signalling entropy in relation to
cellular robustness and specifically to drug resistance in cancer. That sig-
nalling entropy may be informative of a cell’s robustness is a proposal that
stems from a general (but unproven) theorem, first proposed by Manke and
Demetrius [44, 45, 46]: namely, that a system’s entropy and robustness are
correlated. Mathematically, this can be expressed as ∆S∆R > 0, which
states that a positive change in a system’s entropy (i.e. ∆S > 0) must
lead to an increase in robustness (∆R > 0). Now, cells are fairly robust
entities, having evolved the capacity to buffer the intra-and-extracellular
stresses and noise which they are constantly exposed to [47, 39]. Much of
this overall stability and robustness likely stems from the topological fea-
tures of the underlying signaling and regulatory networks, for instance fea-
tures such as scale-freeness and hierarchical modularity, which are thought to
have emerged through natural evolutionary processes such as gene duplica-
tion [10, 48, 49]. However, another key feature which contributes to cellular
robustness is cross-talk and signalling pathway redundancy [47]. Pathway
redundancy refers to a situation where a cell has the choice of transmit-
ting signals via two or more possible routes. In the language of statistical
mechanics, this corresponds to a state of high uncertainty (or entropy) in
signaling. High signalling entropy could thus underpin a cell’s robustness to
perturbations, suggesting that a cell’s entropy and robustness may indeed be
correlated (Fig.2A). Consistent with this, pathway redundancy is also well
recognized to be a key feature underlying drug resistance of cancer cells [50].
Further supporting the notion that entropy and robustness may be cor-
related, we previously showed that (i) cancer is characterised by a global
increase in signalling entropy compared to its respective normal tissue [9],
in line with the observation that cancer cells are specially robust to generic
perturbations, and (ii) that a gene’s differential entropy between normal and
cancer tissue is generally speaking anticorrelated with its differential expres-
sion [9], consistent with the view that cancer cells are specially sensitive
to drug interventions that target overexpressed oncogenes, a phenomenon
known as oncogene addiction (Fig.2B) [3]. Interestingly, the observations
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that differential entropy and differential expression are anti-correlated and
that cancer is characterised globally by an increase in entropy [9], are also
consistent with the prevalent view that most driver mutations are indeed in-
activating, targeting tumor suppressor genes [51, 52, 53]. Hence, based on all
of these observations and insights, we posited that signalling entropy could
also prove useful as a means of predicting drug resistance in cancer cells.
2.2. The Signalling Entropy Method: definitions and construction
Briefly, we review the definitions and construction of signalling entropy
as used in our previous studies [8, 9, 38]. The construction relies on a com-
prehensive and high-confidence PPI network which is integrated with gene
expression data [24, 9] (see Appendix A). Briefly, the PPI is used as a
scaffold, and edge weights are constructed from the gene expression data
to approximate the interaction or signaling probabilities between the corre-
sponding proteins in the PPI. Thus, the gene expression data provides the
biological context in which to modulate the PPI interaction probabilities. To
compute signalling entropy requires the estimation of a stochastic matrix, re-
flecting these interaction probablities over the network.
The construction of the stochastic matrix can proceed in two different ways.
In the earliest studies we used a construction which was done at the level
of phenotypes [8, 9]. Under this model, edge weights wij between proteins
i and j were constructed from the correlation between the expression levels
of the corresponding genes i and j, as assessed over independent samples all
representing the same phenotype. Estimating the correlations over indepen-
dent samples, all within the same phenotype, can be viewed as representing a
multifactorial perturbation experiment, with e.g. genetic differences between
individuals mimicking specific perturbations, and thus allowing influences to
be inferred. Thus, this approach hinges on the assumption that highly corre-
lated genes, whose coding proteins interact, are more likely to be interacting
in the given phenotype than two genes which do not correlate. The use of a
PPI as a scaffold is important to filter out significant correlations which only
result from indirect influences. The correlations themselves can be defined in
many different ways, for instance, using simple Pearson correlations or non-
linear measures such as Mutual Information. For example, one way to define
the weights is as wij =
1
2
(1 + cij) with cij describing the Pearson correla-
tion coefficient between genes i and j. This definition guarantees positivity,
but also treats positive and negative correlations differently, which makes
biological sense because activating and inhibitory interactions normally have
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completely distinct consequences on downstream signalling. Thus, the above
weight scheme treats zero or insignificant correlations as intermediate, con-
sistent with the view that an absent interaction is neither inhibitory nor
activating. However, other choices of weights are possible: e.g. wij = |cij|,
which treats negative and positive correlations on an equal footing. Once
edge weights are defined as above, these are then normalised to define the
stochastic matrix pij over the network,
pij =
wij∑
k∈Ni wik
,
with Ni denoting the PPI neighbors of gene i. Thus, pij is the probability
of interaction between genes i and j, and as required,
∑
j pij = 1. However,
there is no requirement for pij to be doubly stochastic, i.e. P is in general not
a symmetric matrix. Hence, edges are bi-directional with different weights
labeling the probability of signal transduction from i to j, and that from j
to i (pij 6= pji).
An alternative to the above construction of the stochastic matrix is to invoke
the mass action principle, i.e. one now assumes that the probability of inter-
action in a given sample is proportional to the product of expression values
of the corresponding genes in that sample [38]. Thus, the PPI is again used
as a scaffold to only allow interactions supported by the PPI network, but
the weights are defined using the mass action principle, as
wij ∝ EiEj
where Ei denotes the normalised expression intensity value (or normalised
RNA-Seq read count) of gene i. An important advantage of this construction
is that the stochastic matrix is now sample specific, as the expression values
are unique to each sample.
Given a stochastic matrix, pij, constructed using one of the two methods
above, one can now define a local Shannon entropy for each gene i as
S˜i = − 1
log ki
∑
k∈Ni
pik log pik,
where ki denotes the degree of gene i in the PPI network. The normalisa-
tion is optional but ensures that this local Shannon entropy is normalised
between 0 and 1. Clearly, if only one weight is non-zero, then the entropy
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attains its minimal value (0), representing a state of determinism or lowest
uncertainty. Conversely, if all edges emanating from i carry the same weight,
the entropy is maximal (1), representing the case of highly promiscuous sig-
naling. In principle, local Shannon entropies can thus be compared between
phenotypes to identify genes where there are changes in the uncertainty of
signaling. In the case where entropies are estimated at the phenotype level,
jackknife approaches can be used to derive corresponding differential entropy
statistics [9]. Deriving statistics is important because node degree has a dra-
matic influence on the entropy variance, with high degree nodes exhibiting
significantly lower variability in absolute terms, which nevertheless could be
highly significant [9]. In the case where entropies are estimated at the level
of individual samples, ordinary statistical tests (e.g. rank sum tests) can
be used to derive sensible P-values, assuming of course that enough samples
exist within the phenotypes being compared.
In addition to the local entropy, it is also of interest to consider statistical
properties of the distribution of local entropies, for instance their average.
Comparing the average of local entropies between two phenotypes would
correspond to a comparison of non-equilibrium entropy rates. To see this,
consider the formal definition of the entropy rate SR [54, 55], i.e.
SR =
n∑
i=1
piiSi,
where pii is the stationary distribution (equivalently the left eigenvector with
unit eigenvalue) of P (i.e. piP = pi), and where now
Si = −
∑
k∈Ni
pik log pik.
Note that the entropy rate SR is an equilibrium entropy since it involves the
stationary distribution of the random walker. As such, the entropy rate also
depends on the global topology of the network. Thus, the entropy rate is a
weighted average of the local unnormalized entropies, with the weights speci-
fied by the stationary distribution. It follows that comparing the unweighted
averages of local entropies reflects a comparison of a non-equilibrium entropy
rate since the stationary distribution is never used.
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2.3. The importance of the integrated weighted network in estimating sig-
nalling entropy
The entropy rate constructed using the mass action principle is sample
specific. We previously demonstrated that this entropy rate was highly dis-
criminative of the differentiation potential of samples within a developmental
lineage, as well as being highly discriminative of normal and cancer tissue [38]
(Fig.3A). Since the entropy rate takes as input a PPI network and a sam-
ple’s genome-wide expression profile, the significance of the resulting entropy
values, as well as that of the difference between entropy rates, also needs
to be assessed relative to a null distribution in which the putative informa-
tion content between network and gene expression values is non-existent. In
fact, since the weights in the network determine the entropy rate and these
weights are dependent on both the specific network nodes and their respec-
tive gene expression profiles, it is natural to assess the significance of the
entropy rate by “destroying” the mutual information between the network
nodes and their gene expression profiles, for instance by randomising (i.e.
permuting) the gene expression profiles over the network. Thus, under this
randomisation, the topological properties of the network remain fixed, but
the weights are redefined. Application of this randomisation procedure to
the normal/cancer expression set considered previously [38] (Fig.3A) shows
that the discriminatory potential is significantly reduced upon permuting
the gene expression values over the network (Fig.3B-C). Importantly, we
observe that the entropy rate is much higher in the normal and cancer states
compared to the rates obtained upon randomisation of the gene expression
profiles (Fig.3B), indicating that both normal and cancer states are char-
acterised by a higher level of signaling promiscuity compared to a network
with random weights. That the discrimination between normal and cancer is
significantly reduced in the randomly weighted network further demonstrates
that there is substantial mutual information between the PPI network and
the gene expression profiles, thus justifying the signalling entropy approach.
2.4. Signalling entropy R-package: input, output and code availability
A vignette/manual and user-friendly R-scripts that allow computation of
the entropy rate is available at the following url: sourceforge.net/projects/signalentropy/files/.
Here we briefly describe the salient aspects of this package:
The input: The main R-script provided (CompSR) takes as input a user-
specified PPI network, and a genome-wide expression vector representing
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the gene expression profile of a sample. It is assumed that this has been gen-
erated using either Affy, Illumina or RNA-Sequencing. In principle one ought
to use as gene expression value the normalised unlogged intensity (Affy/Illu)
or RNA-seq count, since this is what should be proportional to the number
of RNA transcripts in the sample. However, in practice we advise taking
the log-transformed normalised value since the log-transformation provides
a better compromise between proportionality and regularisation, i.e. some
regularisation is advisable since the underlying kinetic reactions are also reg-
ular.
The output: The R-functions provided in the package then allow the user
to estimate the global entropy rate for a given sample, as well as the local
normalised entropies for each gene in the integrated network. If a phenotype
is specified then genes can be ranked according to the correlation strength of
their local entropy to the phenotype. Thus, the signalling entropy method
allows us to assess (i) if the overall levels of signalling promiscuity is different
between phenotypes, which could be important, for instance, to compare the
pluripotent capacity of iPSCs generated via different protocols or to assess
the stem cell nature of putative cancer stem cells [38], and (ii) to rank genes
according to differential entropy between phenotypes, allowing key signalling
genes associated with differentiation, metastasis or cancer to be identified
[8, 9, 38].
3. Results
3.1. Signalling entropy and cellular robustness
Our previous observation that signalling entropy is increased in cancer
[9], and that one of the key characteristics of cancer cells is their robustness
to intervention and environmental stresses, suggested to us that high cellular
signalling entropy may be a defining feature of a cell that is robust to gen-
eral perturbations. In addition, cancer cells often exhibit the phenomenon of
oncogene addiction, whereby they become overly reliant on the activation of
a specific oncogenic pathway, rendering them less robust to targeted inter-
vention [3]. Since oncogenes are normally overexpressed in cancer, it follows
by the second cancer system-omic hallmark [9], that their lower signalling
entropy may underpin their increased sensitivity to targeted drugs (Fig.2).
Based on these insights, we posited that cellular signalling entropy may be
correlated to the overall cellular system’s robustness to perturbations.
In order to explore the relation between signalling entropy and robustness
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in a general context, it is useful to consider another network property of the
stochastic matrix, namely the global mixing rate. This mixing rate is defined
formally as the inverse of the number of timesteps for which one has to evolve
a random walk on the graph so that its probability distribution is close to the
stationary distribution, independently of the starting node (Appendix B).
This is a notion that is closer to that of robustness or resilience as defined
by Demetrius and Manke [44, 45, 46], allowing the mixing rate to be viewed
as a crude proxy of a system’s overall robustness to generic perturbations.
Furthermore, the global mixing rate can be easily estimated as
µR = − log SLEM (1)
where SLEM is the second largest (right) eigenvalue modulus of the stochas-
tic matrix (Appendix B). Thus, we first asked how this global mixing rate
is related to the signalling entropy rate.
For a regular network of degree d it can be easily shown that the en-
tropy rate SR = log d, whilst results on graph theory also show that for
sufficiently large regular graphs, µR ∝ log d [56]. Hence, at least for regular
networks a direct correlation exists. It follows that for non-regular graphs
with tight degree distributions, e.g. Erdo¨s-Renyi (ER) graphs, the entropy
and mixing rates should also be approximately correlated. Indeed, using
an empirical computational approach to evaluate the entropy and mixing
rates for ER graphs with variable entropy rates, we were able to confirm
this correlation (Appendix C, Fig.4A). Next, we wanted to investigate if
this relationship also holds for networks with more realistic topologies than
ER graphs. Hence, we generated connected networks on the order of 500
nodes by random subsampling 1000 nodes from our large protein interaction
network (∼ 8000 nodes) followed by extraction of the maximally connected
component (Appendix D). We verified that these networks possessed ap-
proximate scale-free topologies with clustering coefficients which were also
significantly higher than for ER graphs. As before, for each generated net-
work, stochastic matrices of variable entropy rates were defined. Signalling
entropy and mixing rates were then estimated for each of these networks,
and subsequently averaged over an ensemble of such graphs. As with the
random Poisson (ER) graphs, average mixing and entropy rates were highly
correlated (Fig.4B).
Having demonstrated a direct correlation between these two measures on
simulated data, we next asked if such a correlation could also be present in
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the full protein interaction networks and with the stochastic matrices de-
rived from real expression data. Thus, we computed the global entropy and
mixing rates for 488 cancer cell lines from the Cancer Cell Line Encylopedia
(CCLE) (Appendix E) [57]. Remarkably, despite the dynamic ranges of
both entropy and mixing rates being much smaller (Fig.4C) compared to
those of the artificially induced stochastic matrices (c.f Fig.4A-B), we were
still able to detect a statistically significant correlation between entropy and
mixing rates, as estimated across the 488 cell lines (Fig.4C). Thus, all these
results support the view that global entropy and mixing rates are correlated,
albeit only in an average/ensemble sense.
3.2. Local signalling entropy predicts drug sensitivity
In the case of realistic expression and PPI data, the observed correla-
tion between entropy and mixing rates was statistically significant but weak
(Fig.4C). This could be easily attributed to the fact that in real biological
networks, the global mixing rate is a very poor measure of cellular robust-
ness. In fact, it is well known that cellular robustness is highly sensitive
to which genes undergo the perturbation. For instance, in mice some genes
are embryonically lethal, whereas others are not [10]. Robustness itself also
admits many different definitions. Because of this, we decided to investigate
signalling entropy in relation to other more objective measures of cellular
robustness. One such measure is drug sensitivity, for instance, IC50 values,
which measure the amount of drug dose required to inhibit cell proliferation
by 50%. According to this measure, a cell that is insensitive to drug treat-
ment is highly robust to that particular treatment. Since most drugs target
specific genes, we decided to explore the relation, if any, between the local
signalling entropy of drug targets and their associated drug sensitivity mea-
sures. Specifically, we hypothesized that since local entropy provides a proxy
for local pathway redundancy, that it would correlate with drug resistance.
To test this, we first computed for each of the 8038 genes in the PPI network
its local signalling entropy in each of the 488 CCLE cancer cell-lines. To
identify associations between the 24 drug sensitivity profiles and the 8038 lo-
cal network entropies, we computed non-linear rank (Spearman) correlation
coefficients across the 488 cancer cell-lines, resulting in 24×8038 correlations
and associated P-values. We observed that there were many more significant
associations than could be accounted for by random chance (Fig.5A), with
the overall strength of association very similar to that seen between gene
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expression and drug sensitivity (Fig.5B).
One would expect the targets of specific drugs to be highly informative of
the sensitivity of the corresponding drugs. We used the CancerResource [58]
to identify targets of the 24 drugs considered here, and found a total of 154
drug-target pairs. For 134 of these pairs we could compute a P-value of as-
sociation between local entropy and drug sensitivity with 76 pairs (i.e. 57%)
exhibiting a significant association (Fig.5C). This was similar to the propor-
tion (54%) of observed significant associations between gene expression and
drug sensitivity (Fig.5D). However, interestingly, only 42 of these significant
drug-target pairs were in common between the 76 obtained using signalling
entropy and the 72 obtained using gene expression. Importantly, while the
significant associations between gene expression and drug sensitivity involved
preferentially positive correlations, in the case of signalling entropy most of
the significant correlations were negative (Fig.5C-D), exactly in line with
our hypothesis that high entropy implies drug resistance. Thus, as expected,
cell-lines with highly expressed drug targets were more sensitive to treatment
by the corresponding drug, but equally, drug targets exhibiting a relatively
low signalling entropy were also predictive of drug sensitivity.
To formally demonstrate that local signalling entropy adds predictive power
over gene expression, we considered bi-variate regression models including
both the target’s gene expression as well as the target’s signalling entropy.
Using such bivariate models and likelihood ratio tests we found that in the
majority of cases where signalling entropy was significantly associated with
drug sensitivity that it did so independently of gene expression, adding pre-
dictive value (Fig.5E). Top ranked drug-target pairs where signalling entropy
added most predictive value over gene expression included Topotecan/TP53
and Paclitaxel/MYC (Fig.5F).
To further demonstrate that the observed associations between local sig-
nalling entropy and drug sensitivity are statistically meaningful, we con-
ducted a control test, in which we replaced in the multivariate model the
signalling entropy of the target with a non-local entropy computed by ran-
domly replacing the PPI neighbours of the target with other “far-away” genes
in the network. For a considerable fraction (41%) of drug-target pairs, the
original multivariate models including the local entropy constituted better
predictive models than those with the non-local entropy (false discovery rate
< 0.25), indicating that the observed associations are driven, at least partly,
by the network structure.
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3.3. High signalling entropy of intra-cellular signaling hubs is a hallmark of
drug resistance
Among the drug-target pairs for which signalling entropy was a significant
predictor of drug sensitivity, we observed a striking non-linear association
with the topological degree of the targets in the network (Fig.6A). In fact,
for hubs in the network, most of which encode nodes located in the intracel-
lular signaling hierarchy, high signalling entropy was exclusively associated
with drug resistance (negative SCC). Examples included well-known intra-
cellular signalling hubs like HDAC1, HDAC2, AKT1, TP53, STAT3, MYC).
Some intracellular non-hubs (e.g. CASP9, BCL2L1, BIRC3) also exhibited
negative correlations between signalling entropy and drug sensitivity. Among
targets for which high signalling entropy predicted drug sensitivity, we ob-
served several membrane receptors (e.g ERBB2, ERBB3, EGFR, MET) and
growth factors (e.g HBEGF, EGF, TGFA). Given that the correlation co-
efficients were estimated across samples (cell-lines) and that the underlying
network topology is unchanged between samples, the observed non-linear re-
lation between the directionality of the correlation and node degree is a highly
non-trivial finding. We also observed a clear dependence on the main signal-
ing domain of the target, with intracellular hubs showing preferential anti-
correlations, in contrast to growth factors and membrane receptors which
exhibited positive and negative correlations in equal proportion (Fig.6B).
Thus, we can conclude from these analyses that cancer associated changes to
the interaction patterns of intra-cellular hubs are key determinants of drug
resistance. In particular, in cancers where the local entropy at these hubs
is increased, as a result of increased promiscuous signaling, drugs targeting
these hubs are less likely to be effective.
4. Discussion and Conclusions
Here we have advocated a fairly novel methodological framework, based
on the notion of signalling entropy, to help analyze and interpret functional
omic data sets. The method uses a structural network, i.e. a PPI network,
from the outset, and integrates this with gene expression data, using local
and global signalling entropy measures to estimate the amount of uncertainty
in the network signaling patterns. We made the case as to why uncertainty or
entropy might be a key concept to consider when analysing biological data.
In previous work [9, 38], we showed how signalling entropy can be used to
estimate the differentiation potential of a cellular sample in the context of
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normal differentiation processes, as well as demonstrating that signalling en-
tropy also provides a highly accurate discriminator of cancer phenotypes.
In this study we focused on a novel application of signalling entropy to under-
standing cellular robustness in the context of cancer drug sensitivity screens.
Our main findings are that (i) local signalling entropy measures add pre-
dictive value over models that only use gene expression, (ii) that the local
entropy of drug targets generally correlates positively with drug resistance,
and (iii) that increased local entropy of intra-cellular hubs in cancer cells is
a key hallmark of drug resistance.
These results are consistent and suggestive of an underlying entropy-robustness
correlation theorem, as envisaged by previous authors [44]. Here, we provided
additional empirical justification for such a theorem, using both simulated as
well as real data, and using drug sensitivity measures as proxies for local ro-
bustness measures. A more detailed theoretical analysis of local mixing and
entropy rates and incorporation of additional information (e.g. phosphory-
lation states of kinases, protein expression,..etc) when estimating entropies
on real data, will undoubtedly lead to further improvements in our systems-
level understanding of how entropy/uncertainty dictates cellular phenotypes.
From a practical perspective, we have already shown in previous work [38]
how local network entropies could be used to identify key signaling path-
ways in differentiation. It will therefore be interesting in future to apply
the signalling entropy framework in more detail to identify specific signaling
nodes/pathways underlying drug sensitivity/resistance.
Our results have also confirmed the importance of network topology (e.g.
hubness and therefore scale-freeness) in dictating drug resistance patterns.
Thus, it will be interesting to continue to explore the deep relation between
topological features such as scale-freeness and hierarchical modularity in rela-
tion to the gene expression patterns seen in normal and disease physiology. It
is entirely plausible that, although our current data and network models are
only mere caricatures of the real biological networks, that underlying funda-
mental systems biology principles characterising cellular phenotypes can still
be gleaned from this data. Indeed, our discovery that increased signalling
entropy correlates with drug resistance demonstrates that such fundamental
principles can already be inferred from existing data resources.
It will also be of interest to consider other potential applications of the sig-
naling entropy method. For instance, one application could be to the iden-
tification of functional driver aberrations in cancer. This would first use
epigenomic (e.g. DNA methylation and histone modification profiles) and
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genomic information (SNPs, CNVs) together with matched gene or protein
expression data to identify functional epigenetic/genetic aberrations in can-
cer. Signalling entropy would subsequently be used as a means of identify-
ing those aberrations which also cause a fundamental rewiring of the net-
work. With multi-dimensional matched omic data readily available from the
TCGA/ICGC, this represents another potentially important application of
the signalling entropy method. Another important future application of the
signaling entropy method would be to single-cell data, which is poised to
become ever more important [59]. So far, all signaling entropy analyses have
been performed on cell populations, yet single-cell analysis will be necessary
to disentangle the entropies at the single-cell and population-cell levels.
In summary, we envisage that signalling entropy will become a key concept
in future analyses and interpretation of biological data.
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Appendix A. The protein protein interaction (PPI) network
We downloaded the complete human protein interaction network from
Pathway Commons (www.pathwaycommons.org) (Jun.2012) [24], which brings
together protein interactions from several distinct sources. We built a pro-
tein protein interaction (PPI) network from integrating the following sources:
the Human Protein Reference Database (HPRD) [23], the National Cancer
Institute Nature Pathway Interaction Database (NCI-PID) (pid.nci.nih.gov),
the Interactome (Intact) http://www.ebi.ac.uk/intact/ and the Molecular In-
teraction Database (MINT) http://mint.bio.uniroma2.it/mint/. Protein in-
teractions in this network include physical stable interactions such as those
defining protein complexes, as well as transient interactions such as post-
translational modifications and enzymatic reactions found in signal trans-
duction pathways, including 20 highly curated immune and cancer signal-
ing pathways from NetPath (www.netpath.org) [60]. We focused on non-
redundant interactions, only included nodes with an Entrez gene ID anno-
tation and focused on the maximally conntected component, resulting in a
connected network of 10,720 nodes (unique Entrez IDs) and 152,889 docu-
mented interactions.
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Appendix B. Mixing rate results for a general random walk on a
connected graph
Suppose that we have a connected graph with an ergodic Markov chain
defined on it, given by a stochastic matrix P with stationary distribution
pi (i.e. piP = pi). We further assume that the detailed balance equation,
piipij = pijpji holds. Defining the diagonal matrix Π ≡ diag(pi1, ..., piN), the
detailed balance equation can be rewritten as ΠP = P TΠ. That the matrix
P is stochastic means that each row of P sums to 1. Equivalently, the vector
with all unit entries, 1, is a right eigenvector of P , i.e. P1 = 1. Note also
that the stationary distribution pi is a left eigenvector of P with eigenvalue
1. The Perron-Frobenius theorem further implies that all other eigenvalues
are less than 1 in magnitude. If detailed balance holds, all eigenvalues are
also real.
The global mixing rate can be defined by considering the rate at which the
node visitation probabilities of a random walker approaches that of the sta-
tionary distribution, independently of the starting position. Formally, if we
let Qi(t) denote the probability that at time t we find the walker at node i,
then the mixing rate, µR, is defined by [61]
µR = lim
t→∞
sup max
i
|Qi(t)− pii|1/t.
Denoting by Q(t) the column vector with elements Qi(t), one can write
Q(t) = (P t)TQ(0).
To determine the elements, Qi(t), of this vector, it is convenient to first
introduce the matrix M = Π
1
2PΠ−
1
2 . This is because M t = Π
1
2P tΠ−
1
2 ,
and so P t can be rewritten in terms of M , but also because M satisfies the
following lemma:
Lemma 1. M has the same eigenvalues as P and if ua is an eigenvector of
M , then ra = Π
− 1
2ua and la = Π
1
2ua are right and left eigenvectors of P .
Proof of Lemma 1. Suppose that Mua = λaua. It then follows that
P (Π−
1
2ua) = λa(Π
− 1
2ua).
In the case of the left-eigenvector, multiply Mua = λaua from the left with
Π
1
2 . Then,
ΠPΠ−1(Π
1
2ua) = λa(Π
1
2ua).
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Detailed balance implies that ΠP = P TΠ, so P T la = λala. Taking the
transpose of this implies that la is indeed a left-eigenvector of P .
The significance of the above lemma becomes clear in light of the detailed
balance equation, which implies that M = MT , and so M and M t can be
orthogonally diagonalized. In particular, we can express Qi(t) in terms of
the eigenvalue decomposition of M t, as
Qi(t) =
∑
a
qa|λa|tu˜aipi1/2i
, where qa =
∑
j u˜ajpi
−1/2
j Qj(0) and where u˜a is the a’th unit norm eigenvector
of M . Since Π
1
21 is the top unit norm eigenvector of M (using previous
lemma), which has an eigenvalue of 1, it follows that q1 = 1 and hence that
Qi(t) = pii +
∑
a≥2
qa|λa|tu˜aipi1/2i .
It follows that
|Qi(t)− pii| =
∑
a≥2
qa|λa|tu˜aipi1/2i .
Since 1 = |λ1| ≥ |λ2| ≥ |λ3| . . ., we can conclude that as t → ∞, the rate at
which Qi approaches the stationary value pii is determined by the modulus
of the second largest eigenvalue (the Second Largest Eigenvalue Modulus-
SLEM). The global mixing rate µR can thus be estimated as
µR ≈ − log |λ2| = − log SLEM
.
Appendix C. Entropy and mixing rates in simulated weighted Erdo¨s-
Renyi graphs
For large regular graphs of degree d, the mixing rate is proportional to
log d [56] and thus directly proportional to the entropy rate (SR = log d for a
regular graph of degree d). By extrapolation, we can thus reasonably assume
that for any sufficiently large graph with a tight degree distribution, such
as random Erdos-Renyi (ER) graphs, that the entropy and mixing rates will
also be correlated, albeit perhaps only in an average ensemble sense. The
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analytical demonstration of this is beyond the scope of this work. Hence, we
adopt a computational empirical approach to see if the entropy and mixing
rates may indeed be correlated. In detail (and without loss of generality
concerning the end result) we considered ER graphs of size 100 nodes and
average degree 10 (other values for these parameters gave similar answers).
We built an ensemble of 100 distinct ER graphs, and for each of these we
constructed a family of weighted networks, parameterised by a parameter
 which controls the level of signalling entropy. Specifically, we gradually
shifted the weight distribution around each node i (with degree di), in such
a way that pij = /di for j 6= k and pij = 1 − di (di − 1) for j = k, with
0 ≤  ≤ 1 and with k labeling a randomly chosen neighbor of node i. Thus, 
is a parameter that directly controls the uncertainty in the information flow,
i.e. the entropy rate, since for  = 1 we have that pij = Aij/di (Aij is the
symmetric adjacency matrix of the graph), whilst for  = 0, pij = δik, i.e.
the information flow from node i can only proceed along one node (node k).
Thus, one would expect the entropy rate to decrease as  is decreased to zero.
For each value of  we thus have an ensemble of 100 ER-graphs, for each of
which the entropy and mixing rates can be computed. Finally, at each value
of  the entropy and mixing rates are averaged over the ensemble.
Appendix D. Entropy and mixing rates in simulated weighted sub-
graphs of a PPI network
The analysis described above was performed also for maximally connected
subnetworks generated from the underlying realistic PPI network described
earlier. Specifically, we randomly subsampled 1000 nodes from the 8038 node
PPI network, and extracted the maximally connected subnetwork, which
resulted (on average) in a subnetwork of approximately 500 nodes. A family
of stochastic matrices of variable entropy rates were constructed as explained
above and for each resulting weighted network we estimated the entropy and
mixing rates. Finally, ensemble averages over 100 different realisations were
computed.
Appendix E. The Cancer Cell Line Encyclopedia (CCLE) data
We used the gene expression data and drug sensitivity profiles as provided
in the previous publication [57]. Briefly, integration of the gene expression
data with our PPI network resulted in a maximally connected component
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consisting of 8038 genes/proteins. There were 488 cell-lines with gene expres-
sion and drug sensitivity profiles for 24 drugs. As a measure of drug response
we used the Activity Area [57] since this measure gave optimal results when
correlating drug response to gene expression levels of well established drug
targets.
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Figure 1: Signalling Entropy: understanding systems biology through uncer-
tainty. A) A caricature model of a cellular interaction network with edge widths/color
indicating the relative probabilities of interaction. On the left and right, we depict states
of high and low signalling entropy, respectively. At the cellular population level, this trans-
lates into samples of high and low intra-sample heterogeneity, respectively. B) Signalling
entropy correlates with pluripotency as demonstrated in our previous work (Banerji et
al 2013). The pluripotent state is a highly promiscuous signaling state, generating high
intra-sample heterogeneity, and allowing the stem cell population to differentiate into any
cell type. In contrast, in a terminally differentiated state, signaling is almost determin-
istic, reflecting activation of very specific pathways in the majority of cells, leading to a
highly homogeneous and differentiated cell population. Thus, signalling entropy defines
the height in Waddington’s differentiation landscape.
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Figure 2: Signalling entropy and cellular robustness: A) Signalling entropy ought
to correlate with cellular robustness. The inequality encapsulates this information by
stating that a decrease in signalling entropy (i.e. if ∆S < 0), then the system’s robustness
R must also decrease, i.e. ∆R < 0, so that the product ∆S∆R > 0. Observe how in
the low entropy state, random removal of edges through e.g. inactivating mutations, can
lead to deactivation of a key signaling pathway connecting a given start and end nodes
(shown in orange). In the high entropy state, the same perturbations do not prevent
signal transduction between the two orange nodes. B) Depicted are the effects of two
major forms of cancer perturbation. In the upper panel, inactivation (typically of tumour
suppressors), leads to underexpression and a corresponding loss of correlations/interactions
with neighbors in the PPI network. This is tantamount to a state of increased entropy
and drug intervention is unlikely to be effective. In the lower panel, we depict the case of
an oncogene, which is overexpressed in cancer. This overexpression leads to activation of a
specific oncogenic pathway which results in oncogene addiction and increased sensitivity to
targeted drug intervention. Thus, local signalling entropy and robustness (as determined
by response to a drug), may also correlate locally.
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Figure 3: Entropy rate in normal and cancer tissue: A) Boxplots of sample specific
entropy rates comparing normal liver and liver cancer samples. Expression data set is the
one used in [38]. B) As A), but also shown are the sample specific entropy rates obtained by
randomly permuting the gene expression values over the network. Note how the entropy
rates for the normal and cancer states are significantly reduced upon permutation and
are no longer highly discriminative between normal and cancer. C) ROC curves and
associated AUC normal-cancer discriminatory values for the unpermuted and permutated
cases depicted in A) and B).
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Figure 4: Correlation between global entropy and mixing rates. A) Plotted is
the entropy rate against the mixing rate for Erdos-Renyi graphs of 100 nodes and average
degree 10. The light blue lines show the results over 100 different network realisations,
with the dark blue line representing the ensemble average. B) As A) but for connected
subnetworks of average size 500 nodes, generated by random subsampling of 1000 nodes
from the full PPI network of 8038 nodes. As in A), a range of edge weight distributions
were considered reflecting variable entropy rates. The light blue lines show the results
over 100 different realisations, with the dark blue line representing the ensemble average.
C) Scatterplot of the global entropy versus mixing rates for the 488 Cancer Cell-Line En-
cyclopedia (CCLE) samples. Spearman rank correlation coefficient (SCC) and associated
P-value are given (left panel). Wilcoxon rank sum test P-value between high and low
mixing rate groups (as defined by tertiles) (right panel).
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Figure 5: Anti-correlation between local signalling entropy and drug sensitivity.
A) Histogram of Spearman rank correlation P-values between drug sensitivities (n=24)
and local signalling entropies (n=8038 genes), as computed over the 488 CCLE cell-lines.
B) As A) but for gene expression instead of signalling entropy. C) Scatterplot of Spear-
man rank Correlation Coefficient (SCC) between local signalling entropy (sigS) and drug
sensitivity (DS) against −log10P-value for each of 134 drug gene target pairs. D) As C)
but for gene expression instead of local entropy. In C) & D), we give the distribution of
significant positive and negative correlations and the associated Binomial test P-value. E)
Drug target gene pairs ranked according to negative SCC (cyan color) between signalling
entropy and drug sensitivity. Only pairs where at least one of entropy or gene expression
were significantly associated are shown. Upper panels show the SCC (cyan=strong nega-
tive SCC, white=zero or non-significant SCC, magenta=strong positive SCC), while lower
panels show the corresponding P-values with the last row showing the P-value from the
Likelihood Ratio Test (LRT) assessing the added predictive value of signalling entropy over
gene expression. The darker the tones of red the more significant the P-values are, whilst
white indicates non-significance. F) A subset of E), with pairs now ranked according to
the LRT P-value.
33
0 200 400 600 800
−
0.
4
−
0.
2
0.
0
0.
2
0.
4
degree
SC
C(
sig
S,D
S)
EC
MR
IC
Erlotinib−ERBB2
Lapatinib−ERBB2
Lapatinib−ERBB3
Paclitaxel−MYC
Panobinostat−HDAC1
Topotecan−TP53
Topotecan−AKT1
l
l
l
l
l
EC+MR (24) IC (50)
−
0.
4
−
0.
2
0.
0
0.
2
0.
4
SC
C(
sig
S,D
S)
P=0.005
EC+MR (24) IC (50)
−
0.
4
−
0.
2
0.
0
0.
2
0.
4
SC
C(
ex
p,
D
S)
P=0.006
Figure 6: High signalling entropy of intra-cellular hubs confers drug resistance:
Upper panel plots the topological degree of drug targets (x-axis) against the Spearman rank
Correlation Coefficient (SCC) between its local signalling entropy and drug sensitivity, as
assessed over the CCLE samples. EC=target annotated as extra-cellular, MR=target
annotated as membrane receptor, IC=target annotated as intra-cellular. Left lower panel
shows the difference in SCC values between the IC and EC+MR targets. Wilcoxon rank
sum test P-value given. Right lower panel shows the difference in SCC values between
the IC and EC+MR targets, where now the SCC value were computed between gene
expression and drug sensitivity. Wilcoxon rank sum test P-value given.
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